Resveratrol reverses monocrotaline-induced pulmonary vascular and cardiac dysfunction: a potential role for atrogin-1 in smooth muscle
about
Sirtuin 1 (SIRT1) activation mediates sildenafil induced delayed cardioprotection against ischemia-reperfusion injury in miceLongitudinal in vivo SPECT/CT imaging reveals morphological changes and cardiopulmonary apoptosis in a rodent model of pulmonary arterial hypertensionMuscle RING finger-1 promotes a maladaptive phenotype in chronic hypoxia-induced right ventricular remodeling.Regulation of Cell Cycle Regulators by SIRT1 Contributes to Resveratrol-Mediated Prevention of Pulmonary Arterial Hypertension.F-BOX proteins in cancer cachexia and muscle wasting: Emerging regulators and therapeutic opportunities.Novel putative pharmacological therapies to protect the right ventricle in pulmonary hypertension: a review of current literature.Cardiac and vascular atrogin-1 mRNA expression is not associated with dexamethasone efficacy in the monocrotaline model of pulmonary hypertension.Resveratrol inhibits hypoxia-induced proliferation and migration of pulmonary artery vascular smooth muscle cells by inhibiting the phosphoinositide 3-kinase/protein kinase B signaling pathway.Monocrotaline-Induced Pulmonary Hypertension Involves Downregulation of Antiaging Protein Klotho and eNOS Activity.Natural Antioxidants as Potential Therapy, and a Promising Role for Melatonin Against Pulmonary Hypertension.Resveratrol as a potential therapeutic drug for respiratory system diseases.Atrogin-1 Increases Smooth Muscle Contractility Through Myocardin Degradation.Beneficial Effect of Ocimum sanctum (Linn) against Monocrotaline-Induced Pulmonary Hypertension in Rats.Myeloid-Derived Suppressor Cells and Pulmonary Hypertension
P2860
Q28539039-8ABB0551-281F-4BBE-BA5A-DAB75738280EQ28729124-8C328F68-644F-4BDF-94DA-9A4B2EBDD02FQ33584306-F9588DE7-EF1B-46E2-8122-3436D11FC66BQ35930978-03A7FDBA-38F3-48B3-B0D0-CEF733A254EFQ38577674-83DF6D18-E617-4079-BD08-6E242DB1BFC3Q39093828-DB75E12E-9B57-4D05-BBDE-DFBE22120951Q42250061-F444F8B9-11D5-408F-B40E-6F4CDD89BC9BQ42347163-B67ECB7E-AB4A-4E67-973E-2E697CC1B797Q42664861-E22CFE61-7CEF-42C3-937B-81F37A569D27Q46183692-F0072E81-9A16-4200-8402-468ECD84825BQ47103368-B92B1E68-5D8A-45EE-8B78-4DDFC1E7DC21Q51647453-FE20A006-85DC-42ED-AE6A-94DCE097B349Q52577533-CD696A38-E81D-4285-A663-89D4A9B5BA55Q58800964-1CD32E15-280A-461D-A36C-F63DCFCAE405
P2860
Resveratrol reverses monocrotaline-induced pulmonary vascular and cardiac dysfunction: a potential role for atrogin-1 in smooth muscle
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Resveratrol reverses monocrota ...... for atrogin-1 in smooth muscle
@ast
Resveratrol reverses monocrota ...... for atrogin-1 in smooth muscle
@en
type
label
Resveratrol reverses monocrota ...... for atrogin-1 in smooth muscle
@ast
Resveratrol reverses monocrota ...... for atrogin-1 in smooth muscle
@en
prefLabel
Resveratrol reverses monocrota ...... for atrogin-1 in smooth muscle
@ast
Resveratrol reverses monocrota ...... for atrogin-1 in smooth muscle
@en
P2093
P2860
P1476
Resveratrol reverses monocrota ...... for atrogin-1 in smooth muscle
@en
P2093
Matthew J Campen
Michael L Paffett
Selita N Lucas
P2860
P356
10.1016/J.VPH.2011.11.002
P577
2011-11-25T00:00:00Z